Archive for August, 2019
The revised “Pharmaceutical Administration Law” allows the online selling of prescription drugs
On August 26th, the revised “Pharmaceutical Administration Law” was approved by the Twelfth Session of the Thirteenth Standing Committee of the National People’s Congress and will come into effect on December 1st, 2019. The “Pharmaceutical Administration Law” proposed that the Marketing Authorisation Holders and pharmaceutical companies can sell drugs online on the premise of complying with relevant provisions. Vaccines, narcotic drugs, and other drugs under special control are not included.
新《药品管理法》对网售处方药开了绿灯
来源：医药网 2019.08.27
8月26日， 新修订版《药品管理法》经十三届全国人大常委会第十二次会议表决通过，并将自2019年12月1日起施行。法案提出，药品上市许可持有人、药品经营企业可在遵守法案关于药品经营的有关规定的前提下通过网络销售药品。疫苗、麻醉药品等国家实行特殊管理的药品不得在网络上销售。
Catalog of medical insurance (2019 Version) is released
On August 21st, the State Council issued the “National Medicine Catalogue of Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance (2019 version),” which will be implemented from January 1st, 2020. The “Medicine Catalogue” Indicates that each provincial Medical Insurance Bureau should bring all the drugs of the “Medicine Catalogue” into the “Centralised Procurement” and update the drug database according to the use of drugs in local medical institutions and retail pharmacies. Meanwhile, a national unified drug database should be established to realise the unified management of codes of western medicine, Chinese traditional medicine, and hospital-made medicines.
2019版国家医保目录正式发布
来源：医药网 2019.08.21
8月21日，国务院发布《国家基本医疗保险、工伤保险和生育保险药品目录》（以下简称《目录》），并自2020年1月1日起开始实施。《目录》要求，各省级医疗保障部门应及时将《目录》内药品纳入当地药品集中采购范围，并根据辖区内医疗机构和零售药店药品使用情况，及时更新完善药品数据库。同时，应建立完善全国统一的药品数据库，实现西药、中成药、中药饮片、医院制剂的编码统一管理。
Heilongjiang: The detailed rules of drug price supervision is going to be implemented
On August 9th, the Medical Insurance Bureau of the Heilongjiang province issued the “Notification of Supervising Drug Price and Distribution Information.” The “Notification” stipulates that the supervision of drug price and distribution information should be carried from drug manufacturers, distribution enterprises, medical institutions, retail pharmacies, and public sentiment. The mechanisms for information collection, reporting, analysis, investigation, and processing should be improved at the provincial, city, and county levels.
药品价格监测地方细则来了！月月报送、五方联动……
来源：医药网 2019.08.12
8月9日，黑龙江省医保局发布了《关于做好药品价格和配送信息检测工作的通知》（以下简称《通知》）。《通知》指出，应从药品生产企业、配送企业、医疗机构、定点零售药店和社会舆情五个方面开展药品价格和配送信息检测；健全并完善省、市、县三级联动的信息采集、报送、分析、调查、处理机制。
The Xi’an Municipal Government launches the submission of increased purchase of selected drugs(“4+7”)
On August 6th, the Xi’an Municipal Government issued the “Notification on Launching the Submission of Increased Purchase of Selected Drugs in Xi’an from the ‘Office of the Leading Group for the Implementation of Centralized Drug Procurement and Pilot Work’”. It is decided to increase the purchase of selected drugs in Xi’an because its procurement exceeds expectations. Besides, the deferred payment of the increased procurement should be paid in time.
“4+7″采购量完成超预期，启动中选药品增加采购量报送
来源：医药网 2019.08.07
8月6日，西安市发布《落实国家组织药品集中采购和试点工作领导小组办公室关于启动西安地区中选药品增加采购量报送工作的通知》。因西安地区”4+7″准备采购量完成情况已经超过预期，经研究，决定启动西安地区中选药品增加采购量报送工作。同时，对于增加的采购量，应确保及时回款。